Polymorphism rs8057341 in the NOD2 gene and its clinical-laboratory association with visceral leishmaniasis
Abstract
Visceral leishmaniasis (VL) is a chronic and debilitating disease with high lethality, characterized by diverse clinical and epidemiological features. Among these, the parasite-host relationship is known to influence disease progression, which can be affected by single nucleotide polymorphisms (SNPs) in genes associated with the immune response. The objective of this study was to evaluate the SNP rs8057341 in the NOD2 gene and its clinical-laboratory association with VL. For this purpose, patients diagnosed with VL (n = 28) were studied. The SNP rs8057341 in the NOD2 gene was genotyped using real-time PCR, and patient data were collected from medical records. Our results showed no association between genotypes and the main symptoms of the disease. However, regarding disease severity, most patients had a severe condition (n = 21), a factor influenced by the AG (p = 0.0455) and GG (p = 0.0110) genotypes, compared to the AA genotype. Based on these findings, we hypothesize that the AA genotype of rs8057341 in the NOD2 gene is associated with susceptibility to L. infantum, possibly by impairing the antiparasitic immune response involved in disease control, with probable modulation of IL-17. However, because it may promote a less intense inflammatory response, it could be associated with milder disease manifestations.
Downloads
Copyright (c) 2026 Acta Scientiarum. Health Sciences

This work is licensed under a Creative Commons Attribution 4.0 International License.
DECLARATION OF ORIGINALITY AND COPYRIGHTS
I Declare that current article is original and has not been submitted for publication, in part or in whole, to any other national or international journal.
The copyrights belong exclusively to the authors. Published content is licensed under Creative Commons Attribution 4.0 (CC BY 4.0) guidelines, which allows sharing (copy and distribution of the material in any medium or format) and adaptation (remix, transform, and build upon the material) for any purpose, even commercially, under the terms of attribution.
Read this link for further information on how to use CC BY 4.0 properly.













5.png)





